Bilateral putaminal hemorrhage with cerebral edema in hyperglycemic hyperosmolar syndrome.

Yonsei Med J

Department of Neurology, Sejong General Hospital, 91-121, Sosa Bon 2-Dong, Sosa-Gu, Bucheon-si, Kyonggi-do 422-232, Korea.

Published: August 2002

Bilateral putaminal hemorrhages rarely occur simultaneously in hypertensive patients. The association of intracerebral hemorrhage with cerebral edema (CE) has been rarely reported in diabetic patients. We present a patient with bilateral putaminal hemorrhage (BPH) and CE during the course of hyperglycemic hyperosmolar syndrome (HHS). A 40-year-old man with a history of diabetes mellitus and chronic alcoholism was admitted with acute impaired mentality. His blood pressure was within the normal range on admission. Laboratory results revealed hyperglycemia and severe metabolic acidosis without ketonuria. After aggressive treatment, plasma sugar fell to 217 mg/dl, but brain CT showed BPH and diffuse CE. Our case demonstrated that HHS should be considered as a cause of BPH with CE. Initial brain imaging study may be recommended for patients with diabetic coma.

Download full-text PDF

Source
http://dx.doi.org/10.3349/ymj.2002.43.4.533DOI Listing

Publication Analysis

Top Keywords

bilateral putaminal
12
putaminal hemorrhage
8
hemorrhage cerebral
8
cerebral edema
8
hyperglycemic hyperosmolar
8
hyperosmolar syndrome
8
edema hyperglycemic
4
syndrome bilateral
4
putaminal hemorrhages
4
hemorrhages rarely
4

Similar Publications

Delayed Diagnosis of Temporomandibular Joint Dislocation in Severe Stroke Patients.

Cureus

September 2024

Department of Neurosurgery, International University of Health and Welfare, Narita Hospital, Narita, JPN.

Article Synopsis
  • - A 79-year-old woman with a history of stroke experienced changes in consciousness and left-sided paralysis, leading to a CT scan that identified a brain hemorrhage.
  • - She required a tracheostomy for breathing support and was initially fed through a nasal tube due to swallowing difficulties.
  • - Imaging later revealed chronic dislocation in both jaw joints, and after a successful procedure to realign the joints, she was able to resume oral feeding, highlighting the need to consider jaw issues in stroke patients with swallowing problems.
View Article and Find Full Text PDF

The relative inability to produce effortful movements is the most specific motor sign of Parkinson's disease, which is primarily characterized by loss of dopaminergic terminals in the putamen. The motor motivation hypothesis suggests that this motor deficit may not reflect a deficiency in motor control per se, but a deficiency in cost-benefit considerations for motor effort. For the first time, we investigated the quantitative effect of dopamine depletion on the motivation of motor effort in Parkinson's disease.

View Article and Find Full Text PDF

Because of the blood-brain barrier (BBB), successful drug delivery to the brain has long been a key objective for the medical community, calling for pioneering technologies to overcome this challenge. Convection-enhanced delivery (CED), a form of direct intraparenchymal microinfusion, shows promise but requires optimal infusate design and real-time distribution monitoring. The size of the infused substances appears to be especially critical, with current knowledge being limited.

View Article and Find Full Text PDF
Article Synopsis
  • - Osmotic Demyelination Syndrome (ODS), commonly seen in alcoholics and malnourished individuals, results in various clinical symptoms affecting speech, language, swallowing, and movement due to demyelination in the brain.
  • - A 36-year-old male with a history of alcohol use and hypertension was diagnosed with ODS after MRI showed specific brain lesions, leading to issues like spastic dysarthria and moderate dysphagia.
  • - After receiving speech and swallowing therapy, the patient showed significant improvement in swallowing ability within 5 days, as measured by the Mann Assessment of Swallowing Ability (MASA), highlighting its effectiveness in assessing dysphagia prognosis in ODS cases.
View Article and Find Full Text PDF

Objective: Gene therapy by convection-enhanced delivery of type 2 adeno-associated virus-glial cell derived neurotrophic factor (AAV2-GDNF) to the bilateral putamina seeks to increase GDNF gene expression and treat Parkinson's disease (PD).

Methods: A 63-year-old man with advanced PD received AAV2-GDNF in a clinical trial. He died from pneumonia after anterior cervical discectomy and fusion 45 months later.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!